Gonorrhea Epidemiology Forecast 2025-2034

Gonorrhea refers to a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. A total of 601,319 gonorrhea cases were reported in 2023 in the United States, which made it rank as the second most common nationally notifiable sexually transmitted infection in the country for that year.

Gonorrhea Epidemiology Forecast Report Coverage

The “Gonorrhea Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of gonorrhea. It projects the future incidence and prevalence rates of gonorrhea across various populations. The study covers age, gender, and type as major determinants of the gonorrhea-affected population. The report highlights patterns in the prevalence of gonorrhea over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of gonorrhea in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Gonorrhea Disease Overview

Gonorrhea is a sexually transmitted bacterial infection that can lead to long-term health issues and infertility. This STI spreads primarily by contact with body fluids or genitals, affecting rectum, throat, genitals, and other parts of the body. Common symptoms include increased vaginal discharge, pain or burning during urination, sharp pain in the lower abdomen, and itching in the anus, among others. Untreated gonorrhea is reported to cause severe health complications such as swelling of the joints and arthritis.

Gonorrhea: Treatment Overview

For the treatment of gonorrhea, antibiotics are given to the patient. Typically, a single shot of ceftriaxone is prescribed, which is injected in the buttocks or thigh. If ceftriaxone is not possible, then cefixime is an alternative treatment. After the administration of antibiotics, the patient can still spread the infection and is advised to avoid sexual activity for up to seven days. A testing for gonorrhea is recommended three months post-treatment.

Epidemiology

The gonorrhea epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for gonorrhea by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for gonorrhea and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Age-specific gonorrhea notification rates were reported to be highest in the 20- to 24-year-olds age category, both for women (48.1 cases/100,000) and men (99.6 cases/100,000), according to the epidemiological data for 2022 retrieved from The European Surveillance System (TESSy).
• The UK Health Security Agency (UKHSA) revealed an increase of 50.3% in gonorrhea diagnoses in 2022 compared to 2021.
• A total of 46,728 confirmed cases of gonorrhea were reported by 27 EU/EEA countries in 2021, as per the European Surveillance System (TESSy). Half of the reported cases included men who have sex with men.
• According to the World Health Organisation (WHO), in 2020, around 82.4 million new Neisseria gonorrhoeae infections occurred among adults globally.

Country-wise Gonorrhea Epidemiology

The gonorrhea epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of gonorrhea varies between countries owing to differences in sexual behaviors, surveillance systems, healthcare access, diagnostic practices, antibiotic resistance patterns, public health interventions, and socio-economic factors. In the United States, 601,319 cases of gonorrhea were reported in 2023, showing a 7.2% decrease in the number of cases compared to 2022.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of gonorrhea based on several factors.
• Gonorrhea Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of gonorrhea are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of gonorrhea epidemiology in the 8 major markets?
• What will be the total number of patients with gonorrhea across the 8 major markets during the forecast period?
• What was the country-wise prevalence of gonorrhea in the 8 major markets in the historical period?
• Which country will have the highest number of gonorrhea patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of gonorrhea during the forecast period of 2025-2034?
• What are the currently available treatments for gonorrhea?
• What are the disease risks, signs, symptoms, and unmet needs of gonorrhea?

This product will be delivered within 3-5 business days.